Priester, Germany

Uwe Eichelberger

This inventor holds 1 USPTO granted patent. Top assignee: Leibniz-Institut Fuer Pflanzenbiochemie (Ipb). Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uwe Eichelberger. Retrieved from https://idiyas.com/inventor/uwe-eichelberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Uwe Eichelberger - An Innovator in Cancer Treatment

Introduction

Uwe Eichelberger is an accomplished inventor based in Priester, Germany. With a keen focus on biochemistry, Uwe has dedicated his work to developing innovative solutions for pressing health issues, particularly in the field of oncology. His passion for research is reflected in his notable contributions to the scientific community.

Latest Patents

Uwe Eichelberger holds a patent titled "Macrocycles for the treatment of cancer." This groundbreaking invention introduces new macrocycles of the general formula (I) and explores their application in treating various cancer diseases. This advancement represents a significant step forward in the quest for effective cancer therapies.

Career Highlights

Uwe is currently affiliated with the Leibniz Institute for Plant Biochemistry (IPB), where he plays a vital role in advancing research in the field of biochemistry and cancer treatment. His expertise and innovative thinking have cemented his reputation as a forward-thinking inventor.

Collaborations

Throughout his career, Uwe has collaborated with esteemed colleagues, including Ludger A Wessjohann and Thao Tran Thi Phuong. These partnerships have enriched his research efforts and expanded the horizons of biochemistry, contributing to the development of effective cancer treatments.

Conclusion

Uwe Eichelberger stands out as a prominent figure in the realm of innovation, particularly in cancer treatment. His dedication to research and collaboration has led to significant contributions that may shape the future of oncological therapies, benefiting countless individuals in their battle against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…